Dr Brian C. Gilger

Department of Clinical Sciences, North Carolina State University, Raleigh, NC, USA

Dr. Brian Gilger received his veterinary degree from The Ohio State University in Columbus, Ohio. After an ophthalmology residency and master’s degree at Auburn University, Dr. Gilger returned to The Ohio State University as an Assistant Professor of Ophthalmology in 1992. In October 1995, he joined the faculty at North Carolina State University as an Associate Professor of Ophthalmology and is now a Professor of Ophthalmology. He is board-certified in Veterinary Ophthalmology and Toxicology, and a Gold Fellow of the Association for Research in Vision and Ophthalmology (ARVO). He was recognized as a distinguished alumnus of both The Ohio State University and Auburn University and, in 2018, was awarded the American Veterinary Medical Association Clinical Research Award. In 2025 he was awarded the Alexander Quarles Holladay Medal, the highest academic award presented to faculty at North Carolina State University.

Dr. Gilger is Associate Editor of Veterinary Ophthalmology and a member of the Editorial Board for Ocular Pharmacology and Therapeutics. Dr. Gilger’s research is focused on ocular drug delivery, immunomodulation, and innovative therapies for ocular disease, including the use of gene and cell therapy. He is the ophthalmology consultant for the CRO Powered Research and co-founder of Bedrock Therapeutics and Astro Therapeutics. He has authored over 200 peer-reviewed scientific manuscripts and is the editor of seven textbooks, including Ocular Pharmacology and Toxicology (2014), Standards in Ocular Toxicology and Inflammation (2018), and four editions of Equine Ophthalmology.

Updated 24 March 2025